cure for heart disease and stroke Part 1
Uploader Comments (bedwards1951)
Video Responses
All Comments (8)
-
This is good information. I disagree with suggesting OTC Niacin to anybody. Considering there are IR, SR, and ER formulations the choices are confusing and pharmacists don't often understand the differences in terms of lipid benefit to safety ratio. The prescription Niacins are about the same as the OTC in terms of cost if you have insurance. But there is too much at stake for a patient who buys OTC Niacin in my opinion.
-
Coronary heart disease is a serious medical disorder and result of unhealthy dietary habits. In 2002, I was so shocked when I discovered I suffered the disease, which I tried to help my patients prevent. View my video by clicking the name of my channel, "carbscankill", and find what I have done for myself, to restore my health.
Robert Su, M.D.
-
Thanx, Dr. Edwards!
-
will this work?? i only take omega 3 fish oil
-
Great presentation ... the video helps me understand the goals of all the testing ... thanks
Endur-acin is only $40 for 1,000 tabs. I don't think any insurance matches that. Niaspan is poorly tolerated due to flushing in comparison to Endur-acin. Stick to endur-acin 500 mg bid and there are few side effects and much benefit. I don't think Slo-niacin is as good in terms of flushing.
bedwards1951 2 years ago
It is great for a person to have a coronary calcium score of zero. However there is still a 15-255 chance of having soft plaque that doesn't show up on the CT scan or EBCT.
I advise to then do a CIMT to check for plaque in the carotids.
This was presented at Radiological Society of North Amercia 94th Scientific Assembly and Annual Meeting. Nov /Dec 2008. Earls,J 3ssk02-03
bedwards1951 3 years ago
I would also advise physicians to check the SHAPE task force guidelines: Naghavi M,Am J Cardiol 2006;98;2h-15h
Coronary Calcium Score reference: J Am Coll Cardiol 2007;49:378-402
bedwards1951 3 years ago
Some physicians might object that I advise evaluation and treatment not advised by the quidelines.
NCEP ATPIII:
Emerging risk factors may be useful in;
1- to elevate intermediate risk pt. to high risk level
2- to guide Rx. if < 2 risk factors and LDL 160-189
3- to improve assessment in middle-aged and older patients in whom traditional risk factors may have declined in predictive power
JAMA 2001; 285:2486-2497
Guidelines are a baseline from which we start, it is the minimum standard.
bedwards1951 3 years ago